Synthesis of 4-Amino-4,5-dihydro-1H-1,2,4-triazole-5-ones and their Isatin-3-imine Derivatives by Kahveci, Bahittin
 





Synthesis of 4-Amino-4,5-dihydro-1H-1,2,4-triazole-5-ones and  
their Isatin-3-imine Derivatives 
Bahittin Kahveci 
 
Department of Chemistry, Rize Faculty of Arts and Science, Karadeniz Technical University, 53100, 
Rize, Turkey. 
 
* Author to whom correspondence should be addressed; e-mail: bahittin@yahoo.com 
 
Received: 12 July 2004 / Accepted: 1 September 2004 / Published: 28 February 2005 
 
 
Abstract: Iminoester hydrochlorides 1 have been synthesized. These compounds were 
then converted into ester ethoxycarbonyl hydrazones 2, from which in turn a new series 
of substituted 4-amino-4,5-dihydro-1H-1,2,4-triazole-5-ones, 3, was then prepared. 
Finally a set of isatin imine derivatives 4 was obtained from the reaction of compounds 3 
with isatin. The structures of all the new synthesized compounds were confirmed by 
elemental analyses, IR, 1H-NMR and 13C-NMR spectra. 





The synthesis and antibacterial activity of some 4-amino-4,5-dihydro-1H-1,2,4-triazoles and their 
derivatives have been reported in the literature [1-5]. A number of studies involving the antibacterial 
and antitumor activity of some 4-amino-4,5-dihydro-1H-1,2,4-triazole-5-ones and their derivatives 
have also been published recently [6-14]. There are also many studies on isatin (1H-indole-2,3-dione) 
in the literature. The synthetic versatility of isatin has led to the extensive use of this compound in 
organic synthesis. This has stemmed in great part from the interest in the biological and 
pharmaceutical properties of its derivatives [15-24]. Although reactions of isatin with many amino 
compounds have been investigated, it appears that its reaction with the N-aminotriazole-5-ones have 
not been studied before. Consequently, some new 4-amino-4,5-dihydro-1H-1,2,4-triazole-5-ones have 
now been synthesized  and their reactions with isatin investigated.  




Results and Discussion 
 
The new derivatives were prepared following the reaction sequences depicted in Scheme 1. 
Iminoester starting materials 1a-d were prepared by passing HCl gas through solutions of 2-chloro-
benzyl cyanide, 3-chlorobenzyl cyanide, 2-methylbenzyl cyanide or 3-methylbenzyl cyanide and 



























In the IR spectra of compounds 1a-d the characteristic NH2+ absorption bands appeared at 2980, 
2920 and 810 cm-1 and the C=N band at 1640 cm-1, approximately. Reaction of the iminoesters with 
ethyl carbazate yielded the ethoxycarbonyl hydrazones 2a-d. The IR spectra of these compounds show 
the C=O band at 1740 cm-1 and the C=N band at 1600 cm-1, approximately. The obtained compounds 
2a-d were then refluxed with a solution of hydrazine hydrate in water to afford the compounds 3a-d. 
The NH2, C=O and C=N bands observed in the IR spectra of the latter compounds match the peaks 
expected for these structures. In addition to this, observation of NH2, NH and aromatic protons, as well 
as the disappearance of CH2CH3 signals in the 1H-NMR spectra and the triazole C5 peak at near δ 154 
ppm and the triazole C3 peak at near δ147 ppm in the 13C-NMR spectra all support this conclusion. 

















































structures of the isatin-3-imines were verified by the presence in the IR spectra of two different C=O 
absorbtion bands at around 1700 cm-1 and C=N bands near 1690 cm-1. In addition to this, the 
appearance of signals corresponding to two different NH protons and the disappearance of the NH2 





New compounds 3a-d, which can be used to prepare many new compounds, have been 
synthesized. Some of the new derivatives might be important biologically active agents. The 
compounds 4a-d are also potential biologically active agents and their medical research applications 






Melting points were determined in open capillary tubes on a Büchi oil heated melting point   
apparatus and are uncorrected. The IR spectra were recorded for KBr pellets on Perkin-Elmer 1600 
FTIR spectrophotometer. 1H-NMR and 13C-MR spectra were recorded on a Varian 200A spectrometer 
(solvent DMSO-d6, TMS as internal standard). Elemental analyses were performed on a Carlo Erba 
1106 CHN analyzer. Starting materials were obtained from Fluka or Aldrich. 
 
Synthesis of Iminoester Hydrochlorides 1a-d. 
 
These were synthesized using the reported method [25]. To an ice-cooled solution of the 
appropriate nitrile (1 mole) in absolute alcohol (1.1 moles), dry hydrogen chloride was added until 1.1 
moles had been absorbed. The resulting solution was then allowed to stand at 0 ºC in the refrigerator 
for 12 hours, after which cold absolute ether was added and the obtained crystals were filtered off 
immediately, washed with cold absolute ether and dried in a dessicator. The following compounds 
were thus prepared: 
 
Ethyl imido-o-chlorophenylacetate hydrochloride (1a): m.p. 95-96 ºC; IR ῡ (cm-1): 2982, 2878, 812 
(NH2+), 1624 (C=N), 753 (1,2-disubstituted benzene ring).  
 
Ethyl imido-m-chlorophenylacetate hydrochloride (1b): m.p. 82-84 ºC; IR ῡ (cm-1): 2989, 2939, 823 
(NH2+), 1649 (C=N), 868, 791, 684 (1,3-disubstituted benzene ring). 
 
Ethyl imido-o-methylphenylacetate hydrochloride (1c): m.p. 80-81 ºC; IR ῡ (cm-1): 2981, 2928, 823 
(NH2+), 1648 (C=N), 747 (1,2-disubstituted benzene ring). 
 
Ethyl imido-m-methylphenylacetate hydrochloride (1d): m.p. 113-114 ºC; IR ῡ (cm-1): 2994, 2862, 
811 (NH2+), 1653 (C=N), 867, 768, 714 (1,3-disubstituted  benzene ring). 





General Procedure for Preparation of Ethyl Substituted Formate Ethoxycarbonyl hydrazones 2a-d. 
 
In a stoppered flask equipped with a magnetic stirrer, the corresponding ethyl imidocarboxylate 
hydrochloride (1a-d, 0.01 mol) was dissolved in absolute ethanol (50 mL) with ice-bath cooling and 
ethyl carbazate (0.01 mol) dissolved in absolute ethanol (20 mL) was then added to this solution. After 
stirring for 6 hr in ice-bath, the mixture was filtered to remove the ammonium chloride which 
separated from the solution and the filtrate was evaporated at 30-35ºC under reduced pressure. The 
solid residue, after drying in a dessicator, was recrystallized from petroleum ether to yield compounds 
2a-d. 
 
Ethyl o-chlorophenylacetate ethoxycarbonyl hydrazone (2a): Prepared from 1a, yield 78%; m.p. 54-55 
ºC; IR ῡ (cm-1): 3274 (N-H), 1721 (C=O), 1648 (C=N), 751 (1,2-disubstituted benzene ring); 1H-
NMR, δ (ppm): 1.18 (t, 3H, CH3), 1.28 (t, 3H, CH3), 3.71 (s, 2H, CH2), 3.96 (q, 2H, CH2), 4.24 (q, 2H, 
CH2), 6.58-7.24 (m, 4H, Ar-H), 8.18 (s, 1H, NH); Calcd. (%) for C13H17N2O3Cl (285): C, 54.78; H, 
6.02; N, 9.84; found (%): C, 54.92; H, 6.01, N, 10.00. 
 
Ethyl m-chlorophenylacetate ethoxycarbonyl hydrazone (2b): Prepared from 1b, 74%; m.p. 47-48 ºC; 
IR ῡ (cm-1): 3247 (N-H), 1709 (C=O), 1648 (C=N), 863, 770, 683 (1,3-disubstituted benzene ring); 
1H-NMR, δ (ppm): 1.19 (t, 3H, CH3), 1.24 (t, 3H, CH3), 3.64 (s, 2H, CH2), 3.91(q, 2H, CH2), 4.11 (q, 
2H, CH2), 6.80-7.11 (m, 4H, Ar-H), 8.23 (s, 1H, NH); Calcd. (%) for C13H17N2O3Cl (285): C, 54.78; 
H, 6.02; N, 9.84; found (%): C, 54.48; H, 6.18, N, 10.27. 
 
Ethyl o-methylphenylacetate ethoxycarbonyl hydrazone (2c): Prepared from 1c, yield 80%; m.p. 66-67 
ºC; IR ῡ (cm-1): 3207 (N-H), 1702 (C=O), 1657 (C=N), 747 (1,2-disubstituted benzene ring); 1H-NMR, 
δ (ppm): 1.20 (t, 3H, CH3), 1.32 (t, 3H, CH3), 2.30 (s, 3H, CH3), 3.64 (s, 2H, CH2), 4.00 (q, 2H, CH2), 
4.24 (q, 2H, CH2), 6.96-7.30 (m, 4H, Ar-H); Calcd. (%) for C14H20N2O3 (264): C, 63.56; H, 7.63; N, 
10.60; found (%): C, 63.68; H, 7.89, N, 10.86. 
 
Ethyl m-methylphenylacetate ethoxycarbonyl hydrazone (2d): Prepared from 1d, yield 86%; m.p. 59-
60 ºC; IR ῡ (cm-1): 3257 (N-H), 1710 (C=O), 1648 (C=N), 873, 755, 694 (1,3-disubstituted benzene 
ring); 1H-NMR, δ (ppm): 1.21 (t, 3H, CH3), 1.28 (t, 3H, CH3), 2.28 (s, 3H, CH3), 3.60 (s, 2H, CH2), 
4.08 (q, 2H, CH2), 4.20 (q, 2H, CH2), 6.96-7.54 (m, 4H, Ar-H), 8.46 (s, 1H, NH); Calcd. (%) for 
C14H20N2O3 (264): C, 63.56; H, 7.63; N, 10.60; found (%): C, 63.65; H, 7.89, N, 10.58. 
 
General Procedure for the Preparation of 3-Substituted-4-amino-4,5-dihydro-1H-1,2,4-triazole-5-
ones 3a-d. 
 
Compound 2 (0.01 mol) was refluxed for 5 hr with a solution of hydrazine hydrate (1.25 mL) in 
water (60 mL). The solution was crystallized by cooling to obtain the crude product (3a-d). The solid 
material thus obtained was filtered off and recrystallized from ethanol.   
 




3-o-Chlorobenzyl-4-amino-4,5-dihydro-1H-1,2,4-triazole-5-one (3a): Prepared from 2a, yield 88%; 
m.p. 164-165 ºC; IR ῡ (cm-1): 3338, 3217 (NH2, NH), 1720 (C=O), 1633 (C=N), 749 (1,2-disubstituted 
benzene ring); 1H-NMR, δ (ppm): 4.10 (s, 2H, CH2), 5.28 (s, 2H, NH2), 7.25 (s, 4H, Ar-H), 11.90 (s, 
1H, NH); 13C-NMR, δ (ppm): 28.80, 124.63, 126.84, 130.13, 132.86, 136.90, 138.63, 145.10, 153.14;. 
Calcd. (%) for C9H9N4OCl (225): C, 48.08; H, 4.04; N, 24.94; found (%): C, 48.40; H, 4.54, N, 24.68. 
 
3-m-Chlorobenzyl-4-amino-4,5-dihydro-1H-1,2,4-triazole-5-one (3b):Prepared from 2b, yield 83%; 
m.p. 171-172 ºC; IR ῡ (cm-1): 3324, 3224 (NH2, NH),  1730 (C=O), 1638 (C=N), 864, 793, 719 (1,3-
disubstituted benzene ring); 1H-NMR, δ (ppm): 4.00 (s, 2H, CH2), 5.18 (s, 2H, NH2), 7.16 (s, 4H, Ar-
H), 11.10 (s, 1H, NH); 13C-NMR, δ (ppm): 29.62, 125.54, 127.84, 131.14, 133.62, 136.95, 137.44, 
146.93, 154.11; Calcd. (%) for C9H9N4OCl (225): C, 48.08; H, 4.04; N, 24.94; found (%): C, 48.34; H, 
4.63, N, 24.85. 
 
3-o-Methylbenzyl-4-amino-4,5-dihydro-1H-1,2,4-triazole-5-one (3c): Prepared from 2c, yield 91%; 
m.p. 190-191 ºC; IR ῡ (cm-1): 3327, 3221 (NH2, NH), 1725 (C=O), 1635 (C=N), 736 (1,2-disubstituted 
benzene ring); 1H NMR, δ (ppm): 2.38 (s, 3H, CH3), 4.10 (s, 2H, CH2), 5.28 (s, 2H, NH2), 7.32 (s, 4H, 
Ar-H), 11.60 (s, 1H, NH); 13C-NMR, δ (ppm): 20.12, 29.76, 124.86, 125.18, 129.26, 130.18, 134.10, 
135.19, 146.13, 153.81; Calcd. (%) for C10H12N4O (204): C, 58.76; H, 5.92; N, 27.42; found (%): C, 
58.86; H, 6.04, N, 27.31. 
 
3-m-Methylbenzyl-4-amino-4,5-dihydro-1H-1,2,4-triazole-5-one (3d): Prepared from 2d, yield 87%; 
m.p.156-157 ºC; IR ῡ (cm-1): 3322, 3222 (NH2, NH), 1731 (C=O), 1642 (C=N), 822, 751,  705 (1,3-
disubstituted benzene ring); 1H-NMR, δ (ppm): 2.38 (s, 3H, CH3), 4.16 (s, 2H, CH2), 5.24 (s, 2H, 
NH2), 7.24 (s, 4H, Ar-H), 11.46 (s, 1H, NH); 13C-NMR, δ (ppm): 19.08, 28.12, 125.70, 126.56, 
129.01, 129.78, 134.27, 136.17, 147.28, 154.00; Calcd. (%) for C10H12N4O (204): C, 58.76; H, 5.92; 
N, 27.42; found (%): C, 58.69; H, 6.12, N, 27.96. 
 
General Procedure for the Preparation of Isatin-3-imines 4a-d. 
 
Equimolar quantities (0.01 mol) of isatin and the corresponding amino compound 3a-d were 
dissolved in warm ethanol (40 mL) containing glacial acetic acid (0.5 mL). The reaction mixture was 
refluxed for 4 hr and then kept at room temperature overnight. The resulting solid was washed with 
ethanol, dried and recrystallized from ethanol-chloroform to afford compounds 4a-d. 
 
3-[3’-(4’’-o-Chlorobenzyl-4’,5’-dihydro-1’H-1’,2’,4’-triazol-5’-on-4’-yl]-iminoisatin (4a): Prepared 
from 3a, yield 72%; m.p. 252-253 ºC; IR ῡ (cm-1): 3403, 3190 (N-H), 1754,1730 (C=O), 1684, 1613 
(C=N), 1463 (C=C); 1H-NMR, δ (ppm): 4.18 (s, 2H, CH2), 7.18-7.64 (m, 8H, Ar-H), 11.22 (s, 1H, N-
H), 12.40 (s, 1H, N-H); 13C-NMR, δ (ppm): 29.26, 113.42, 115.80, 121.18, 125.50, 126.18, 128.88, 
129.85, 131.60, 133.36, 134.81, 137.18, 144.81, 145.83, 146.12, 156.18, 161.86 ; Calcd. (%) for 
C17H12N5O2Cl (354): C, 67.66; H, 3.42; N, 19.79; found (%): C, 57.18; H, 3.52, N, 19.64. 
 




3-[3’-(4’’-m-Chlorobenzyl)-4’,5’-dihydro-1’H-1’,2’,4’-triazol-5’-on-4’-yl]-iminoisatin (4b): Prepared 
from 3b, yield 68%; m.p. 266-267 ºC; IR ῡ (cm-1): 3164, 3086 (N-H), 1730, 1708 (C=O), 1684, 1613 
(C=N), 1464 (C=C); 1H-NMR, δ (ppm): 4.14 (s, 2H, CH2), 6.96-7.32 (m, 6H, Ar-H), 7.40-7.68 (s, 2H, 
Ar-H), 11.28 (s, 1H, N-H), 12.36 (s, 1H, N-H); 13C-NMR, δ (ppm): 28.31, 112.41, 116.42, 120.00, 
124.81, 127.51, 128.12, 129.24, 131.18, 132.41, 135.40, 136.02, 145.10, 145.91, 146.83, 157.16, 
162.15; Calcd. (%) for C17H12N5O2Cl (354): C, 57.66; H, 3.42; N, 19.79; found (%): C, 57.89; H, 3.48, 
N, 19.69. 
 
 3-[3’-(4’’-o-Methylbenzyl)-4’,5’-dihydro-1’H-1’,2’,4’-triazol-5’-on-4’-yl]-iminoisatin (4c): Prepared 
from 3c, yield 74%; m.p. 269-270 ºC; IR ῡ (cm-1): 3194, 3088 (N-H), 1746, 1706 (C=O), 1610, 1588 
(C=N), 1467 (C=C); 1H-NMR, δ (ppm): 2.44 (s, 3H, CH3), 4.08 (s, 2H, CH2), 6.92-7.66 (m, 8H, Ar-
H), 11.12 (s, 1H, N-H), 12.54 (s, 1H, N-H); 13C-NMR, δ (ppm): 19.10, 29.33, 111.16, 115.73, 122.41, 
125.74, 127.10, 127.90, 129.37, 130.04, 133.33, 135.54, 136.53, 145.70, 146.10, 148.54, 158.04, 
163.31; Calcd. (%) for C18H15N5O2 (333): C, 64.80; H, 4.54; N, 21.00; found (%): C, 64.96; H, 4.66, 
N, 21.44. 
 
3-[3’-(4’’-m-Methylbenzyl)-4’,5’-dihydro-1’H-1’,2’,4’-triazol-5’-on-4’-yl]-iminoisatin (4d): Prepared 
from 3d, yield 75 %; m.p. 272-273 ºC; IR õ (cm-1): 3177, 3084 (N-H), 1748, 1707 (C=O), 1609, 1583 
(C=N), 1466 (C=C); 1H-NMR δ (ppm): 2.41 (s, 3H, CH3), 4.12 (s, 2H, CH2), 7.00-7.47 (m, 8H, Ar-H), 
11.20 (s, 1H, N-H), 12.32 (s, 1H, N-H); 13C-NMR, δ (ppm): 19.04, 28.96, 112.86, 114.61, 121.14, 
124.81, 127.00, 127.50, 128.14, 131.14, 132.15, 135.20, 135.41, 144.62, 146.54, 147.51, 157.60, 
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